The regulatory framework for transplantation in the United States is governed by the Organ Procurement and Transplant Network (OPTN), a federally established process that is managed by an independent contractor. A component of the guidance of the OPTN is that transplant centers and organ procurement organizations (OPOs) will be subject to transparent and recurring analysis of their individual performance. With a continued disparity between the supply and the demand of transplantable organs, the systems established to evaluate performance must critically assess where opportunities for improvement exist.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Gerber DA, Chapman WC. The Current Opaque State of Organ Donation Metrics in the United States. JAMA Surg. Published online December 02, 2020. doi:10.1001/jamasurg.2020.5396
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: